DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Krop I, Saura C, Yamashita T. et al.
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Previously Treated With T-DM1: DESTINY-Breast01 Study. SABCS 2019, San Antonio/Texas, USA, Dezember 2019, oral presentation GS1-03.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.